Other Species / Isoforms
  VGLL1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K5-ub
___MEEMkKTAIRLP
0 1
VGLL1 (human) ___MEEMkKTAIRLP K5-ub
VGLL1 (mouse) ___MEEMKKNGVWIP K5
K13-ub
KTAIRLPkGKQKPIK
0 1
VGLL1 (human) KTAIRLPkGKQKPIK K13-ub
VGLL1 (mouse) KNGVWIPESSQKPVK E13
S62-p
PQELTPSsQSEGVML
0 1
VGLL1 (human) PQELTPSsQSEGVML S62-p
VGLL1 (mouse) PHKCSSSSHSDNLTL S62
S76-p
LKNDDSMsPNQWRYS
0 1
VGLL1 (human) LKNDDSMsPNQWRYS S76-p
VGLL1 (mouse) KGTNKSMPPNQRHLS P115
S84-p
PNQWRYSsPWTKPQP
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • transcription, induced
Putative in vivo kinases:
  • RSK2 (human)
Treatment
  • siRNA
  • TGF-beta
  • U0126
view more >
VGLL1 (human) PNQWRYSsPWTKPQP S84-p
VGLL1 (mouse) PPNQRHLSSWTIAQP S122
S116-p
PMAVNQFsPSLARRA
0 2
VGLL1 (human) PMAVNQFsPSLARRA S116-p
VGLL1 (mouse) LKAMDQHSLSMPKTP S154
S124-p
PSLARRAsVRPGELW
0 2
VGLL1 (human) PSLARRAsVRPGELW S124-p
VGLL1 (mouse) LSMPKTPSALPLEPW S162
S223-p
YVSRGSAsTSLPNET
0 1
VGLL1 (human) YVSRGSAsTSLPNET S223-p
VGLL1 (mouse) ICARGAASASLDDER S287